Takayuki Morimoto

12PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Instruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 25, 2026
A Prognostic Model Incorporating Age and Systemic Inflammation Response Index for Primary CNS Lymphoma.

|Nov 11, 2025
Postoperative Seizures Can Predict Overall Survival of Patients With Newly Diagnosed Supratentorial Isocitrate Dehydrogenase-Wild Glioblastoma Treated With Radiotherapy Plus Concomitant and Adjuvant Temozolomide.

Kengo Yamada, Ryosuke Matsuda, Ryota Sasaki

|Jun 19, 2024
Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.

Tsutomu Nakazawa, Takayuki Morimoto, Ryosuke Maeoka

|Feb 24, 2024
Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis.

Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Matsuda

|Sep 28, 2023
Therapeutic Anti-KIR Antibody of 1-7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom.

Ryosuke Maeoka, Tsutomu Nakazawa, Ryosuke Matsuda

|Feb 11, 2023
Natural Killer Cell-Based Immunotherapy against Glioblastoma.

Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Maeoka

Pageof 2

Frequent Collaborators

12 joint publications

Ichiro Nakagawa

11 joint publications

Ryosuke Matsuda

10 joint publications

Tsutomu Nakazawa

9 joint publications

Shuichi Yamada